Proton NMR-Based Metabolite Analyses of Archived Serial Paired Serum and Urine Samples From Myeloma Patients at Different Stages of Disease Activity Identifies Acetylcarnitine as a Novel Marker of Active Disease

PLoS ONE - United States
doi 10.1371/journal.pone.0056422
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)


Related search